Investing Profile

Michael Powell

InvestorVC
Executive Partner at Omega Funds
Photo of Michael Powell, Partner at Omega Funds

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Omega Funds Partner
$100K - $5.0M
$1.5M
15
CompanyStageDateRound SizeTotal Raised
Aerium Therapeutics
Series AMar 2022
Co-investors: Vincent Ossipow (Omega Funds), Stephen Knight (F-Prime Capital (formerly Fidelity Biosciences))
Checkmate Pharmaceuticals
Series CJun 2020$85M
Series BJun 2017$27M
Series AAug 2015$20M
$150M
Co-investors: Corey Goodman (venBio Partners), Ben Auspitz (Curie.Bio), Daniel Coley (BrightEdge (American Cancer Society Impact Fund))
Veridium
Series BJun 2018$17M
$17M
Pionyr Immunotherapeutics
Series BDec 2017$62M
$79M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Arjun Goyal (Vida Ventures, LLC), Jack Kenney (Estuary Capital Management, LP), Leon Chen (The Column Group)
Mirna Therapeutics
Series DApr 2015$42M
Series COct 2012$35M
$77M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Bill Harrington (Osage University Partners (OUP)), Geeta Vemuri (Agent Capital)
Labrys Biologics
Series AJan 2013$31M
$31M
Co-investors: Nina Kjellson (Canaan Partners), Wende Hutton (Canaan Partners)
Intellikine
Series BJul 2009$51M
Series BJun 2007$30M
$81M
DiObex
Series BApr 2007$24M
Series ASep 2005$7M
$31M
Sign in with Google →
Sign in with Google →